HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yeongyu Moon Selected Research

KRC-108

7/2022Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yeongyu Moon Research Topics

Disease

3Neoplasms (Cancer)
07/2022 - 01/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2020 - 01/2018
1Colonic Neoplasms (Colon Cancer)
07/2022
1Thyroid Neoplasms (Thyroid Cancer)
01/2021
1Leukemia
06/2020

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
07/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2021
2tyrosine receptor (receptor, tyrosine)IBA
06/2020 - 01/2018
1Phospholipases (Phospholipase)IBA
07/2022
1KRC-108IBA
07/2022
1Pharmaceutical PreparationsIBA
01/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018

Therapy/Procedure

1Therapeutics
01/2021
1Oral Administration
01/2021
1Intravenous Administration
01/2018